Moderna

Moderna is a biotechnology company that develops and manufactures mRNA-based vaccines and therapeutics. It is known for its COVID-19 vaccine and is now developing personalized cancer vaccines.

Why it’s in the news: It is in the news due to a surge in its stock price following a U.S. Treasury announcement and positive developments in its cancer vaccine research.

Latest on Moderna

• CNA Explains: What we know about the Moderna, Merck breakthrough cancer vaccine
• Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped
• Quant funds rocked as Treasury boosts buybacks and Moderna shares leap
• Moderna pins hopes on ‘game-changer’ for cancer vaccines
• U.S. Stocks Up as Treasury Buybacks Calm Bond Yields; Moderna Surges
• Moderna, Merck breakthrough could usher in wave of cancer vaccines

Connections

11 entities linked to Moderna across the news graph.